TMDX R&D to Revenue

Transmedics Group Inc · R&D to Revenue

TMDX logo

TMDX R&D to Revenue

Latest reported11.40%
TMDX FY R&D/Revenue (251.84% → 11.40%)
High-resolution chart · PNG

TMDX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Transmedics Group Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
11.4047%
12.6756%
26.1842%
28.6885%
73.703%
73.4467%
84.1806%
104.909%
194.6259%
251.8441%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.